je.st
news
Amgen: Its biosimilar version of Humira about as effective
2015-02-04 00:09:02| Biotech - Topix.net
Biologic drugmaker Amgen says its biosimilar version of rheumatoid arthritis drug Humira worked similarly in a key head-to-head test. Amgen Inc. says its ABP 501 produced similar results in the percentage of patients in the 26-week, late-stage study who saw improvements in pain, ability to function and number of swollen and tender joints.
Tags: version
effective
amgen
humira
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||